Impact of prophylactic human papillomavirus vaccines on dermatology and venereology

Giornale Italiano di Dermatologia e Venereologia

Volumn 143, Issue 4, 2008, Pages 259-265

  Gross, G ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Anus neoplasms; Condylomata acuminata; Genital neoplasms, female; Human papillomavirus vaccine 11, type 6, 11, 16, 18; Human papillomavirus vaccine, L1 type 16, 18; Papillomavirus vaccines

Indexed keywords

WART VIRUS VACCINE;

ANUS CARCINOMA; CONDYLOMA ACUMINATUM; DRUG APPROVAL; GENITAL TRACT CANCER; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; LUNG TUMOR; ORGAN TRANSPLANTATION; PAPILLOMATOSIS; PENIS CARCINOMA; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA;

EID: 55749089886     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
2. Wiatrak BJ. Overview of recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg 2003;11:433-41.
3. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
4. Gross G, für das Deutsche HPV-Management-Forum Wer soll wann, wo und wie geimpft werden. Antworten des HPV-Management-Forums auf viel diskutierte Fragen, die mit Einführung von zwei unterschiedlichen HPV-Impfstoffen zur Prävention des Zervixkarzinoms und der Condylomata acuminata im Zusammenhang stehen. Dtsch Ärztebl 2006;103:3384-8.
5. Pathirana D, Hillemanns P, Petry KU, Becker N, Brockmeyer NH, Erdmann R et al. Impfprävention HPV-assoziierter Neoplasien. Chemother J 2008;4:120-71.
6. Petry KU. What does HPV vaccination mean for gynecologic cancer screening? Hautarzt 2007;58:501-6.
7. Gross G. HPV-vaccination against cervical carcinoma: will it really work? Med Microbiol Immunol 2007;196:121-5.
8. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-63.
9. Chuang TY, Perry HO, Kurland LT, Ilstrup DM. Condyloma acuminatum in Rochester, Minn., 1950-1978 1. Epidemiology and clinical features. Arch Dermatol 1984;120:469-75.
10. Simms I, Fairley CK. Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med 1997;73:365-7.
11. Lee J, Smith R. Recurrent respiratory papillomatosis: pathogenesis to treatment. Curr Opin Otolaryngol Head Neck Surg 2005;13:354-9.
12. Center of Disease Control and Prevention. Age-adjusted cancer strategies. Center of Disease Control and Prevention, Atlanta, GA, USA; 2002.
13. Cupp MR, Malek RS, Goellner JR, Smith TF, Espy MJ. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol. 1995 Sep;154(3):1024-9.
14. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005;116:606-16.
15. Dillner J, Krogh G von, Horenblas S, Meijer CJ. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 2000;205:189-93.
16. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001;159:1211-8.
17. Strickler HD, Schiffman MH, Shah KV, Rabkin CS, Schiller JT, Wacholder S et al. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev 1998;7:305-13.
18. Gerber GS. Carcinoma in situ of the penis. J Urol 1994;151:829-33.
19. Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 2004;193:35-44.
20. Iversen T, Tretli S. Intraepithelial and ivasive squamous cell neoplasia of the vulva: trends in incidence, recurrence and survival rate in Norway. Obstet Gynecol 1998;91:969-72.
21. Breese PL, Judson FN, Penley KA, Douglas JM Jr. Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 1995;22:7-14.
22. Critchlow CW, Hawes SE, Kuypers JM, Goldbaum GM, Holmes KK, Surawicz CM, Kiviat NB. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS. 1998 Jul 9;12(10):1177-84.
23. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:1350-8.
24. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst. 2001 Jun 6;93:843-9.
25. Palefsky JM, Holly EA, Ralston ML, Arthur SP, Hogeboom CJ, Darragh TM. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med 1997;73:174-80.
26. Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine MD et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004;31:96-9.
27. Paidas CN, Morreale RF, Holoski KM, Lund RE, Hutchins GM. Septation and differentiation of the embryonic human cloaca. J Pediatr Surg 1999;34:877-84.
28. Pao CC, Tsai PL, Chang YL, Hsieh TT, Jin JY. Possible non-sexual transmission of genital human papillomavirus infections in young women. Eur J Clin Microbiol Infect Dis 1993;12:221-2.
29. Tay SK, Ho TH, Lim-Tan SK. Is genital human papillomavirus infection always sexually transmitted? Aust N Z J Obstet Gynaecol 1990;30:240-2..
30. Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999;75:317-9.
31. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500-10.
32. Steinberg BM, DiLorenzo TP. A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev 1996;15: 91-2.
33. Klussmann JP, Dinh S, Guntinas-Lichius O, Wittekindt C, Weissenborn S, Wieland U et al. HPV-associated tonsillar cancer. An update. HNO 2004;52:208-18.
34. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005;32 Suppl 1:859-66.
35. Naghashfar Z, McDonnell PJ, McDonnell JM, Green WR, Shah KV. Genital tract papillomavirus type 6 in recurrent conjunctival papilloma. Arch Ophthalmol 1986;104:1814-5.
36. De Villiers EM, Sandstrom RE, zur Hausen H, Buck CE. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 2005;7: R1-R11.
37. Byrne MA, Taylor-Robinson D, Munday PE, Harris JR. The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS 1989;3:379-82.
38. De Villiers EM. Prevalence of HPV 7 papillomas in the oral mucosa and facial skin of patients with human immunodeficiency virus. Arch Dermatol 1989;125:1590.
39. Frazer IH, Medley G, Crapper RM, Brown TC, Mackay IR. Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet 1986;2:657-60.
40. Greenspan D, de Villiers EM, Greenspan JS, de Souza YG, zur Hausen H. Unusual HPV types in oral warts in association with HIV infection. J Oral Pathol 1988;17:482-8.
41. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93:843-9.
42. French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000;1:107-15.
43. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 2002;186:1023-7.
44. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001;15:2157-64.
45. Palefsky JM. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol 2000;27: 471-9.
46. Palefsky JM, Holly EA, Efirdc JT, Da Costa M, Jay N, Berry JM et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005;19:1407-14.
47. Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001;184:547-51.
48. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-26. Erratum in: Am J Epidemiol 2003;157:858.
49. Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis 2005;191 Suppl 1:S97-S106.
50. Chang MH, Chen TH, Hsu HM, Wu TC, Kong MS, Liang DC et al. Taiwan Childhood HCC Study Group. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 2005;11:7953-7.
51. Block SL, Nolan T, Sattler C, Barr E, Giacoletti KE, Marchant CD et al. Protocol 016 Study Group. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006;118: 2135-45.
52. Palefsky J. Human papillomavirus-associated malignancies in HIV-positive men and women. Curr Opin Oncol 1995;7:437-41.
53. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S et al. IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8.